HIV treatment outcomes in Europe and North America: what can we learn from the differences?

被引：9
|
作者：
Ambrosioni, Juan [1 ,2 ]
Nicolas, David [1 ]
Agueero, Fernando [1 ]
Manzardo, Christian [1 ]
Miro, Jose M. [1 ]
机构：
[1] Univ Barcelona, Infect Dis Serv, Hosp Clin IDIBAPS, Barcelona, Spain
[2] Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2014年 / 12卷 / 05期
关键词：
access to antiretroviral therapy; antiretroviral treatment; cascade of care; Europe; HIV infection; HIV testing; North America; outcome; retention in care; treatment as prevention; ILLEGAL IMMIGRANTS; CARE; SPAIN;
D O I：
10.1586/14787210.2014.906900
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The access to antiretroviral treatment has been largely enlarged in Europe and North America in recent years, due to treatment guidelines that recommend earlier initiation of therapy. However, there are differences and heterogeneities in the health systems and in access and retention to care between different countries and regions, and for different subpopulations among the same country that impact in the final goal, that patients remain undetectable and in good health. © 2014 Informa UK, Ltd.
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
12345